Kbc Group Nv Alnylam Pharmaceuticals, Inc. Transaction History

Kbc Group Nv

$33.1 Billion
Q3 2024

A detailed history of Kbc Group Nv transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Kbc Group Nv holds 24,566 shares of ALNY stock, worth $6.11 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

24,566

Previous 15,096 62.73%

Holding current value

$6.11 Million

Previous $3.67 Million 84.21%

% of portfolio

0.02%

Previous 0.01%

36 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$233.81 - $287.01 $2.21 Million - $2.72 Million	9,470 Added 62.73%	24,566 $6.76 Million
Q1 2024 May 08, 2024	BUY	$146.51 - $198.2 $173,907 - $235,263	1,187 Added 8.53%	15,096 $2.26 Million
Q4 2023 Feb 13, 2024	SELL	$151.41 - $196.57 $5,147 - $6,683	-34 Reduced 0.24%	13,909 $2.66 Million
Q3 2023 Feb 15, 2024	BUY	$170.77 - $211.65 $237,370 - $294,193	1,390 Added 9.84%	15,510 $2.75 Million
Q2 2023 Feb 15, 2024	BUY	$185.01 - $212.05 $1.16 Million - $1.33 Million	6,294 Added 80.42%	14,120 $2.68 Million
Q2 2023 Jul 28, 2023	SELL	$185.01 - $212.05 $2.57 Million - $2.94 Million	-13,886 Reduced 49.9%	13,943 $2.65 Million
Q1 2023 Feb 14, 2024	BUY	$182.66 - $235.53 $3.95 Million - $5.09 Million	21,629 Added 339.17%	28,006 $5.61 Million
Q1 2023 May 04, 2023	BUY	$182.66 - $235.53 $3.68 Million - $4.75 Million	20,172 Added 263.45%	27,829 $5.58 Million
Q4 2022 Feb 14, 2024	SELL	$185.53 - $241.31 $236,921 - $308,152	-1,277 Reduced 16.68%	6,377 $1.52 Million
Q3 2022 Feb 15, 2024	SELL	$138.54 - $232.0 $842,738 - $1.41 Million	-6,083 Reduced 43.73%	7,826 $1.57 Million
Q3 2022 Nov 08, 2022	BUY	$138.54 - $232.0 $30,201 - $50,576	218 Added 2.93%	7,657 $1.53 Million
Q2 2022 Feb 14, 2024	BUY	$120.42 - $169.29 $25,890 - $36,397	215 Added 2.89%	7,654 $1.12 Million
Q1 2022 Feb 14, 2024	BUY	$127.18 - $173.91 $25,436 - $34,782	200 Added 2.76%	7,439 $1.22 Million
Q1 2022 May 06, 2022	BUY	$127.18 - $173.91 $25,436 - $34,782	200 Added 2.76%	7,439 $1.22 Million
Q4 2021 Feb 14, 2024	SELL	$159.56 - $209.29 $1.06 Million - $1.4 Million	-6,670 Reduced 47.95%	7,239 $1.23 Million
Q4 2021 Feb 03, 2022	SELL	$159.56 - $209.29 $1.21 Million - $1.59 Million	-7,610 Reduced 51.25%	7,239 $1.23 Million
Q3 2021 Nov 10, 2021	BUY	$169.75 - $207.73 $140,383 - $171,792	827 Added 5.9%	14,849 $2.8 Million
Q2 2021 Aug 11, 2021	BUY	$128.63 - $176.89 $572,789 - $787,691	4,453 Added 46.54%	14,022 $2.38 Million
Q3 2020 Oct 28, 2020	SELL	$121.19 - $165.49 $1.84 Million - $2.51 Million	-15,159 Reduced 61.3%	9,569 $1.39 Million
Q2 2020 Aug 10, 2020	BUY	$104.21 - $156.44 $1.21 Million - $1.82 Million	11,659 Added 89.21%	24,728 $3.66 Million
Q1 2020 May 04, 2020	BUY	$93.12 - $133.99 $191,640 - $275,751	2,058 Added 18.69%	13,069 $1.42 Million
Q4 2019 Feb 11, 2020	BUY	$74.51 - $124.23 $25,705 - $42,859	345 Added 3.23%	11,011 $1.27 Million
Q3 2019 Nov 07, 2019	BUY	$70.9 - $87.82 $751,610 - $930,979	10,601 Added 16309.23%	10,666 $857,000
Q2 2019 Dec 03, 2019	SELL	$65.86 - $92.79 $500,601 - $705,296	-7,601 Reduced 99.15%	65 $5,000
Q2 2019 Jul 30, 2019	BUY	$65.86 - $92.79 $500,601 - $705,296	7,601 Added 11693.85%	7,666 $0
Q1 2019 Dec 03, 2019	SELL	$72.76 - $93.45 $553,048 - $710,313	-7,601 Reduced 99.15%	65 $6,000
Q1 2019 May 10, 2019	BUY	$72.76 - $93.45 $553,048 - $710,313	7,601 Added 11693.85%	7,666 $0
Q4 2018 Dec 03, 2019	SELL	$62.67 - $88.33 $476,354 - $671,396	-7,601 Reduced 99.15%	65 $5,000
Q4 2018 Jan 31, 2019	BUY	$62.67 - $88.33 $476,354 - $671,396	7,601 Added 11693.85%	7,666 $558,000
Q3 2018 Dec 03, 2019	SELL	$87.52 - $122.67 $665,239 - $932,414	-7,601 Reduced 99.15%	65 $6,000
Q3 2018 Nov 14, 2018	BUY	$87.52 - $122.67 $665,239 - $932,414	7,601 Added 11693.85%	7,666 $0
Q2 2018 Dec 03, 2019	SELL	$88.31 - $107.8 $671,244 - $819,387	-7,601 Reduced 99.15%	65 $6,000
Q2 2018 Aug 03, 2018	BUY	$88.31 - $107.8 $671,244 - $819,387	7,601 Added 11693.85%	7,666 $0
Q1 2018 Dec 03, 2019	SELL	$115.92 - $148.54 $881,107 - $1.13 Million	-7,601 Reduced 99.15%	65 $8,000
Q4 2017 Feb 07, 2018	BUY	$114.49 - $139.98 $769,258 - $940,525	6,719 Added 709.5%	7,666 $0
Q3 2017 Nov 13, 2017	BUY	$72.53 - $118.27 $68,685 - $112,001	947	947 $0

Others Institutions Holding ALNY

# of Institutions

642

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30.6B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account